Health Catalyst Newsroom

Health Catalyst Analyst Ratings

BenzingaJul 9 11:06 ET

Strong Recovery and Expansion Forecast Justifies Buy Rating for Health Catalyst

TipRanksJul 1 06:09 ET

Health Catalyst Analyst Ratings

BenzingaJun 6 09:37 ET

Health Catalyst Analyst Ratings

BenzingaMay 21 15:04 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Curis (CRIS), Health Catalyst (HCAT) and Innate Pharma SA (OtherIPHYF)

TipRanksMay 14 21:55 ET

Health Catalyst Analyst Ratings

BenzingaMay 10 11:51 ET

Strong Q1 Performance and Strategic Ignite Platform Launch Underpin Buy Rating for Health Catalyst (HCAT)

TipRanksMay 10 07:10 ET

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Bluebird Bio (BLUE) and Viatris (VTRS)

TipRanksMay 10 06:06 ET

Buy Rating Affirmed for Health Catalyst Amid Solid Growth and Strategic Financial Management

TipRanksMay 10 06:06 ET

KeyBanc Keeps Their Hold Rating on Health Catalyst (HCAT)

TipRanksMay 10 02:50 ET

Analysts' Top Healthcare Picks: Health Catalyst (HCAT), Sartorius (GB:0NIQ)

TipRanksMay 1 05:20 ET

R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space

Seeking AlphaApr 10 12:58 ET

What 7 Analyst Ratings Have To Say About Health Catalyst

BenzingaApr 10 11:00 ET

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target

BenzingaApr 10 10:16 ET

Health Catalyst Analyst Ratings

BenzingaApr 10 04:44 ET

Health Catalyst Analyst Ratings

BenzingaMar 5 12:37 ET

Buy Rating on Health Catalyst: Strategic Innovation and Client Growth Poised to Drive Performance

TipRanksMar 5 06:10 ET

Barclays Issues a Buy Rating on Health Catalyst (HCAT)

TipRanksMar 5 03:21 ET

RBC Capital Remains a Hold on Health Catalyst (HCAT)

TipRanksFeb 26 07:36 ET

Maintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth Forecast

TipRanksFeb 26 06:35 ET